Venous and arterial thromboembolic risk of JAK inhibitors: a systematic review with meta-analysis.
Rheumatology (Oxford, England)（2023）
摘要
JAKi do not increase thromboembolic risk compared with placebo in IMIDs patients enrolled in selected RCTs.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要